Copyright
©The Author(s) 2017.
World J Hepatol. Jul 8, 2017; 9(19): 850-856
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.850
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.850
Table 3 Predictors of survival using Kaplan-Meier survival curves
| Test | End point | P value (log rank) | Cohort size |
| Baseline Hepascore alone | Composite Endpoint | < 0.001 | 346 |
| LRD | < 0.001 | 352 | |
| LD | < 0.001 | 348 | |
| HCC | < 0.001 | 350 | |
| Delta Hepascore | Composite Endpoint | 0.004 | 96 |
| LRD | 0.048 | 105 | |
| LD | 0.001 | 101 | |
| HCC | 0.178 | 100 |
- Citation: Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World J Hepatol 2017; 9(19): 850-856
- URL: https://www.wjgnet.com/1948-5182/full/v9/i19/850.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i19.850